 |
|
|
May 8, 2003
Torii Pharmaceutical Co., Ltd. |
|
| Notice Concerning Acquisition of the Company's Own Shares in
the Market |
| (Based on Japanese Commercial Code Article 210 Concerning Share
Acquisition) |
|
| Torii Pharmaceutical Co., Ltd. announced that at the Board of
Directors' Meeting held on May 8, 2003, a resolution was approved to propose to
the 111th ordinary general meeting of shareholders on June 24, 2003 the acquisition
of its own shares in accordance with Japanese Commercial Code Article 210, with
details as follows. |
| 1. |
Reason for shares acquisition |
| |
In order to implement flexible capital policies in accordance
with the business environment. |
| 2. |
Details of the acquisition |
|
| (1) |
Type of shares to be acquired : |
common stock |
| (2) |
Total number of shares to be
acquired : |
1,000,000 shares(maximum)
(3.5% of total issued shares) |
| (3) |
Total value of shares to be acquired: |
¥1,800,000,000 (maximum) |
|
(Note)
The above proposal, "Acquisition of the Company's Own Shares," is subject
to approval at the 111th ordinary general meeting of shareholders to be held on
June 24, 2003. |
|
|
|
| |
|
|
|
|
